A 2-month-old female with worsening cough, respiratory distress and an abnormal chest X-ray was referred to our institution for further evaluation of suspected scimitar syndrome. She was found to have normal pulmonary venous drainage with a large patent ductus arteriosus and severe pulmonary arterial hypertension. Chest CT was suggestive of interstitial lung disease. Wedge lung biopsy revealed alveolar simplification and patchy pulmonary interstitial glycogenosis. A definitive diagnosis of Filamin A deficiency was made with genetic studies. The patient is currently showing clinical improvement on systemic glucocorticoid therapy.
To document the outcomes of embolotherapy for pulmonary arteriovenous malformation (pAVM) management, and investigate factors associated with pAVM persistence after embolotherapy in pediatric patients with hereditary hemorrhagic telangiectasia (HHT). Pediatric patients with HHT who received embolotherapy for pAVMs at the institute were retrospectively identified from January 1st, 1999, to January 31st, 2024. Cases with adequate clinical and imaging follow-up and without prior pAVM treatment at another institute were included. Demographic, clinical, and procedural data were obtained from the electronic health record. Univariate Cox proportional hazard models were used to determine factors associated with primary pAVM persistence (re-establishment of an arteriovenous connection in a pAVM after the first embolotherapy). Twenty-one patients (median age=15 years; range:3-19 years) underwent embolotherapy for 65 different pAVMs (Median follow-up time=7.56 years; range:0.13-24.4 years). In total, 3 procedural adverse events occurred. Primary persistence occurred in 23.1% of the treated pAVMs with recanalization only being the most common cause of (73.3%) followed by untreated feeders (20.0%) and recanalization along with formation of new collaterals to the pAVM (6.67%). Age less than the median cutoff of 15 years (p=0.044) and greater maximum diameter of the plugs/coils (p=0.011) were significantly associated with primary persistence on univariate analysis. Embolotherapy of pAVMs in pediatric patients with HHT is safe, with a high rate of persistence when predominantly coils are used. The risk of primary persistence was associated with age less than 15 years, and the use of larger diameter plugs/coils.
Apoptosis-inducing factor mitochondria-associated 1 (AIFM1) gene encodes a mitochondrial flavoprotein that mediates caspase-independent programmed cell death. We report a novel AIFM1 variant in 2 siblings with early-onset hearing loss and progressive cerebellar ataxia. We evaluated the clinical features, brain MRI scans, EMG studies, and whole genome sequencing (WGS). Sibling A is a 19-year-old man with auditory neuropathy at age 15 years, who subsequently developed optic atrophy, progressive gait and limb ataxia, peripheral neuropathy, and ambulation with cane by age 17 years. Brain MRI was normal. Sibling B is a 13-year-old boy with auditory neuropathy diagnosed at 7 and gait instability at 13, with rapid development of peripheral neuropathy, cerebellar ataxia, muscle weakness and atrophy needing wheelchair for mobility, and neuromuscular respiratory failure requiring noninvasive ventilation. Brain MRI showed mild cerebellar atrophy. Initial EMGs showed axonal neuropathy in both and diffuse chronic and active anterior horn cell disorder later in Sibling B. WGS revealed an X-linked, maternally inherited novel AIFM1 variant (c.1299C>G p. Ile433Met). AIFM1 variants should be considered in patients with hereditary cerebellar ataxia and auditory neuropathy. We highlight a novel AIFM1 variant and its phenotypic intrafamilial variability expanding the knowledge of the genetic spectrum of AIFM1-related diseases.
1 December 2017 in Pediatric Allergy, Immunology, and Pulmonology
An 11-month-old healthy infant girl was noted to have left lower lobe (LLL) opacities on chest X-ray (CXR) after developing desaturations during an elective cochlear implant surgery. Repeat CXR 10 days later revealed hyperexpansion of the left lung and persistent LLL opacity. Chest computerized tomography revealed enlarged mediastinal lymph nodes, left mainstem bronchial obstruction, and nodular opacities. Bronchoscopic biopsy of the endobronchial tissue revealed multiple necrotizing granulomas and grew Mycobacterium avium-intracellulare, Streptococcus viridans, and Actinomyces odontolyticus. This case illustrates the potential for significant mediastinal lymphadenopathy, and endobronchial and parenchymal lesions caused by nontuberculous mycobacteria, which can present insidiously and without respiratory symptoms in otherwise healthy infants, despite advanced pulmonary disease.